S&P・Nasdaq 本質的価値 お問い合わせ

Aclarion, Inc. ACONW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
46/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Aclarion, Inc. (ACONW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

アナリスト予想 一株当たり利益(EPS) $-7,371.68 および 売上高 $0.00B 来期予想.

一株当たり利益(EPS)実績推移: 2024: 実績 $-7,480.21 vs 予想 $-7,371.68 (下回る -1.5%). 2025: 実績 $-13.61 vs 予想 $-15.13 (上回る +10%). アナリスト精度: 94%.

EPS予測 — ACONW

94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$7,480.21 vs Est –$7,371.68 ▼ 1.5% off
2025 Actual –$13.61 vs Est –$15.13 ▲ 11.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

売上高予測 — ACONW

89%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.000B vs Est $0.000B ▼ 20.3% off
2025 Actual $0.000B vs Est $0.000B ▼ 1.7% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る